Fulcrum Therapeutics, Inc (FULC) insider trading
Every open-market stock purchase and sale by Fulcrum Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Kevin Tang (Insider) bought $1.5M in the last 90 days.
Last 12 months: insiders bought $1.5M (2 buys) and sold $59.2M (7 sales). Last close $3.70 on Jul 22, 2026.
Recent FULC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 17, 2026 | Kevin Tang (Insider) | Bought | $179K |
| Jul 16, 2026 | Kevin Tang (Insider) | Bought | $415K |
| Jul 15, 2026 | Kevin Tang (Insider) | Bought | $382K |
| Jul 14, 2026 | Kevin Tang (Insider) | Bought | $272K |
| Jul 14, 2026 | Kevin Tang (Insider) | Bought | $191K |
| Jul 13, 2026 | Kevin Tang (Insider) | Bought | $45.9K |
| Jun 26, 2026 | Alan Ezekowitz (Insider) | Sold | $65.6K |
| Apr 23, 2026 | Joshua Lehrer-Graiwer (Insider) | Bought (not open market) | — |
| Feb 2, 2026 | Robert J Gould (Insider) | Sold | $161K |
| Feb 2, 2026 | Alan A Musso (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | Curtis Gale Oltmans (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Alex Sapir (Insider) | Bought (not open market) | — |
| Feb 2, 2026 | Greg Tourangeau (Insider) | Bought (not open market) | — |
| Jan 2, 2026 | Robert J Gould (Insider) | Sold | $178K |
| Jan 2, 2026 | Robert J Gould (Insider) | Sold | $163K |
| Dec 15, 2025 | Curtis Gale Oltmans (C-suite exec) | Sold | $44.6K |
| Dec 8, 2025 | Ra Capital Management L.p. (Insider) | Sold | $38.6M |
| Dec 8, 2025 | Ra Capital Management L.p. (Insider) | Sold | $18.4M |
| Dec 8, 2025 | Ra Capital Management L.p. (Insider) | Sold | $1.4M |
| Nov 19, 2025 | Robert J Gould (Insider) | Sold | $165K |
Who's trading FULC
- Kevin Tang, Insider: bought $1.5M (6 buys), last Jul 17, 2026
- Alan Ezekowitz, Insider: sold $65.6K (1 sale), last Jun 26, 2026
- Joshua Lehrer-Graiwer, Insider: other filings, last Apr 23, 2026
- Alex Sapir, Insider: other filings, last Feb 2, 2026
- Greg Tourangeau, Insider: other filings, last Feb 2, 2026
- Robert J Gould, Insider: sold $668K (4 sales), last Feb 2, 2026
- Alan A Musso, CFO: other filings, last Feb 2, 2026
- Curtis Gale Oltmans, C-suite exec: sold $44.6K (1 sale), last Feb 2, 2026
- Ra Capital Management L.p., Insider: sold $58.4M (3 sales), last Dec 8, 2025
Get free alerts when an insider at Fulcrum Therapeutics, Inc files a new trade →